AngioDynamics
ANGO
168 hedge funds and large institutions have $606M invested in AngioDynamics in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 18 closing their positions.
775% more call options, than puts
Call options by funds: $2M | Put options by funds: $228K
11% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 18
10% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 59
5% more capital invested
Capital invested by funds: $577M → $606M (+$29.5M)
1% more funds holding
Funds holding: 167 → 168 (+1)
0.29% more ownership
Funds ownership: 96.76% → 97.04% (+0.29%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$8M |
| 2 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$6.71M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$5.01M |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$3.25M |
| 5 |
Millennium Management
New York
|
+$2.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
RGM Capital
Naples,
Florida
|
-$11.5M |
| 2 |
Renaissance Technologies
New York
|
-$3.6M |
| 3 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$3.32M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.23M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.48M |
ANGO Hedge Fund Activity: Q3 2017 in Review
168 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2017, worth a combined $606M — up 5.1% from $577M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ANGO positions and 18 closed out — a net gain of 2 holders — while 65 added to existing stakes and 59 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $8M. The largest seller was RGM Capital, exiting entirely with an estimated $11.5M sold.
- 168 institutional investors held AngioDynamics (ANGO) as of Q3 2017, up from 167 in Q2 2017.
- Funds reported $606M of AngioDynamics stock for Q3 2017, up 5.1% quarter-over-quarter.
- 20 funds opened new AngioDynamics positions in Q3 2017 and 18 closed out, a net change of +2 holders.
- The largest AngioDynamics buyer in Q3 2017 was Janus Henderson Group, an estimated $8M added.
- The largest AngioDynamics seller in Q3 2017 was RGM Capital, an estimated $11.5M sold.
Based on aggregated 13F filings for Q3 2017.